Clinical Trials Sponsored by Yunnan Cancer Hospital

Total 10267 results

Yunnan Cancer Hospital

Recruiting

The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial. (WINDOW)

Clinical Complete Response Rate With Negative MRD

China
Fudan University
Zhejiang Cancer Hospital; Huashan Hospital; Henan Cancer Hospital; Hunan Cancer... and other collaborators

Not yet recruiting

Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction (CAPPELLA)

Breast Cancer

China
Yunnan Cancer Hospital
Beijing Bethune Charitable Foundation

Recruiting

Single-arm, Single-center, Exploratory Phase II Clinical Study of Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer (ESTIMATE)

Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer

China
Fuwai Yunnan Cardiovascular Hospital

Completed

An Epidemiological Investigation on Correct Wearing of Mask by Direct Spray Test

Respiratory Infectious Diseases

China
Hunan Cancer Hospital

Not yet recruiting

Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.

Breast Cancer | Endocrine Therapy | CDK4/6 Inhibitors | Subsequent Treatment
Hunan Cancer Hospital

Recruiting

Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients

Breast Neoplasms | Neoplastic Cells, Circulating | Chemotherapy Effect

China
Hunan Cancer Hospital

Completed

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC

Metastatic Colorectal Adenocarcinoma

China
Hunan Cancer Hospital

Completed

Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer

Colorectal Cancer

China
Hunan Cancer Hospital

Completed

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer

Metastatic Colorectal Adenocarcinoma

China
Hunan Cancer Hospital

Completed

Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer

Metastatic Colorectal Adenocarcinoma

China
Hunan Cancer Hospital

Unknown

PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage

Lymphoma

China
Hunan Cancer Hospital

Recruiting

A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC

Carcinoma, Non-Small-Cell Lung

China
Hunan Cancer Hospital

Recruiting

UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases

Brain Metastases | Capecitabine | Metastatic HER2 Negative Breast Carcinoma | UDT1

China
Hunan Cancer Hospital

Recruiting

AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer

Ovarian Cancer

China
Hunan Cancer Hospital

Completed

Real World Study on the Efficacy and Safety of Anti-HER2 Therapy

Breast Neoplasms | HER2-positive Breast Cancer

China
Hunan Cancer Hospital

Completed

Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer (ACTDNA)

Metastatic Breast Cancer | Circulating Tumor DNA | Gene Abnormality
Fuwai Yunnan Cardiovascular Hospital

Not yet recruiting

Treatment of Moderate FMR During AVR

Functional Mitral Regurgitation
Fuwai Yunnan Cardiovascular Hospital

Completed

An Epidemiological Investigation on the Correct Wearing of Face Mask

Respiratory Infectious Diseases

China
Fuwai Yunnan Cardiovascular Hospital

Completed

An Epidemiological Investigation on Correct Wearing of Mask by Hood Test

Respiratory Infectious Diseases

China
Hunan Cancer Hospital

Recruiting

Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Hunan Cancer Hospital

Recruiting

Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy

Triple Negative Breast Neoplasms

China
Hunan Cancer Hospital

Not yet recruiting

Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure

Melanoma
Hunan Cancer Hospital

Recruiting

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Herpesvirus 4, Human

China
Hunan Cancer Hospital

Recruiting

Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer

HR+/HER2- Breast Cancer

China
Hunan Cancer Hospital

Not yet recruiting

Research on Optimization and Evaluation of Oral Cancer Screening Methods

Oral Cancer
Hunan Cancer Hospital

Recruiting

Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma

Chemotherapy Effect | NK/T-cell Lymphoma of Nasal Cavity | Immune Checkpoint Inhibitor | Epigenetic Disorder

China
Hunan Cancer Hospital

Recruiting

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

Ovarian Cancer

China
Hunan Cancer Hospital

Completed

Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Hunan Cancer Hospital

Completed

Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer (ACTDNAGLT)

Metastatic Breast Cancer | Circulating Tumor DNA | Gene Abnormality
Hunan Cancer Hospital

Unknown

A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer

Ovarian Cancer

China
Yunnan AIDS Care Center

Unknown

Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients

HIV Infections | HBV Coinfection

China
Yan'an Affiliated Hospital of Kunming Medical University
The First People's Hospital of Yunnan

Completed

Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis

Lupus Nephritis | Mesenchymal Stem Cells
Hunan Province Tumor Hospital
Hunan Cancer Hospital

Recruiting

Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases (EPIC)

Non-Small Cell Lung Cancer

China
Affiliated Hospital of Yunnan University
Kunming Medical University; Yunnan University

Completed

A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults

COVID-19

China
Affiliated Hospital of Yunnan University

Not yet recruiting

Research on Three-level Prevention and Intervention for Elderly Depression in Urban Community

Depression in Old Age
Hunan Cancer Hospital
Hunan Medical University General Hospital

Not yet recruiting

A Real-world Study of Inetetamab for First-line Treatment of MBC

Breast Cancer | Real-world Study
Yanyan Liu

Recruiting

Linperlisib Combined With Chidamide in Patients With PTCL

Peripheral T-cell Lymphoma

China
Zhan Yunfan

Recruiting

Safety and Efficacy of Shi's Traumatology Osteopathic Manipulative Treatment for Cervicogenic Dizziness (SESTOMTCD)

Cervicogenic Dizziness

China
Zhan Yunfan

Completed

Imaging Characteristics of Chronic Lumbar Disc Herniation From the Perspective of Core Muscles and Subcutaneous Fat Tissue Thickness (ICCLDHPCMSFT)

Lumbar Disc Herniation

China
Fujian Cancer Hospital
Hunan Cancer Hospital; Wuhan TongJi Hospital

Not yet recruiting

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Small Cell Lung Cancer

China
China National Center for Cardiovascular Diseases
Fuwai Yunnan Cardiovascular Hospital

Recruiting

HuoXin Pills Intervention on Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation (HAPPY-DCB)

Coronary Heart Disease | Medicine, Chinese Traditional

China
Hunan Cancer Hospital
Hutchison Medipharma Limited

Not yet recruiting

Fruquintinib Plus FOLFIRI in RAS-mutated Metastatic Colorectal Cancer

Colorectal Cancer

China
M.D. Anderson Cancer Center
Duncan Family Institute

Unknown

A Social Media Approach to Improve Genetic Risk Communication Phase I

Hereditary Diseases

United States
Chengdu CoenBiotech Co., Ltd
Hunan Cancer Hospital

Completed

Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)

Non-muscular Invasive Bladder Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Yunnan Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

SARS-CoV2 Infection

China
Shanghai Public Health Clinical Center
Yunnan AIDS Care Center; Xixi Hospital of Hangzhou

Active, not recruiting

Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection

HIV-1-infection

China
Cancer Institute and Hospital, Chinese Academy...
Yunnan Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

SARS-CoV-2 Infection

China
Second Affiliated Hospital of Nanchang University
Fujian Cancer Hospital; Hunan Cancer Hospital

Not yet recruiting

Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases (CBC)

Non Small Cell Lung Cancer | Brain Metastases
Hunan Cancer Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Hunan Provincial People's...

Unknown

Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer

Non-small Cell Lung Cancer

China
Hunan Children's Hospital

Not yet recruiting

VOICE Study in China 'Towards a Partnership Between Parents of Very Premature Infants and Healthcare Professionals' (VOICE)

Infant ALL | Parents | Emotional Stress | Neonatal Intensive Care | Family Centered Care | Family Separation | Parents Support

3

Subscribe